Sanofi-Aventis and Bristol-Myers Squibb have cut a deal with a generic company that could keep a copycat version of their multibillion drug Plavix off the market until 2011. Sanofi-Aventis and Bristol ...

Shares in Bristol-Myers Squibb continued to decline on Friday as expectation grew that a generic form of its big-selling antithrombotic Plavix could be on the market in the USA later this year. Shares ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

Plavix (clopidogrel) can cause side effects that range from mild to serious. More common side effects include bruising, bleeding, and itching. If side effects from Plavix become difficult to tolerate, ...

A federal appeals court upheld Friday an injunction preventing Apotex Corp. from selling its generic version of Plavix, a blockbuster blood thinner marketed by Bristol-Myers Squibb and Sanofi-Aventis.

NEW YORK, Jan 22 (Reuters) - A lawyer for Sanofi-Aventis and Bristol-Myers Squibb Co. urged a U.S. judge to uphold the patent on blockbuster anti-clotting medication Plavix on Monday, as a high-stakes ...

AP - The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, ...

NEW YORK — An economics professor at the Massachusetts Institute of Technology testified Monday that there will be “significant price erosion” in the drug Plavix, even if a federal judge grants a ...